Cardiovascular magnetic resonance (CMR) study.


December 29, 2009 - In patients with known or suspected myocardial infarction, cardiovascular magnetic resonance (CMR) provides a comprehensive, multifaceted view of the heart, according to a study published in the Dec. 29, 2009 to Jan. 5, 2010 issue of Journal of the American College of Cardiology.

Kim and colleagues review the data, which indicate that delayed enhancement (DE)-CMR is a well-validated, robust technique. Because DE-CMR can differentiate between ischemic and various nonischemic forms of myocardial injury, it is especially useful when there is diagnostic uncertainty. Furthermore, CMR provides clinically relevant information, such as residual viability, microvascular damage, stunning, and right ventricular infarction. Because quantification of infarct size by DE-CMR is highly reproducible, it may provide a useful surrogate end point for clinical trials.

Source: Kim, H.; Farzaneh-Far, A.; Kim, R. "Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications." Journal of the American College of Cardiology. Dec. 29, 2009/Jan. 5, 2010. Vol. 55, No. 1

For more information: content.onlinejacc.org


Related Content

News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now